Baroda BNP Paribas Health and Wellness Fund Regular Growth
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 09-06-2025
AUM:
₹ 0 Cr
Expense Ratio
2.28%
Benchmark
BSE Healthcare TRI
ISIN
INF251K01UY7
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
500
Fund Manager
Mr. Sanjay Chawla
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Baroda BNP Paribas Health and Wellness Fund Regular Growth | - | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
9.8698
Last change
-0.01 (-0.1084%)
Fund Size (AUM)
₹ 0 Cr
Performance
-1.4% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Fund Manager
Mr. Sanjay Chawla
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| Clearing Corporation of India Ltd | 13.52 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 12.09 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 5.9 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.59 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 5.51 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 5.16 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 4.78 |
| FORTIS HEALTHCARE LIMITED. EQ | 4.03 |
| GLAND PHARMA LIMITED EQ NEW FV Re.1/- | 3.6 |
| ABBOTT INDIA LIMITED EQ | 3.59 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 90.63 |
| Financial Services | 2.66 |